Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Martin Schmid

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
European Clinical Respiratory Journal|January 28, 2025
Idiopathic subglottic stenosis in a 32-year-old pregnant womanBo Toennesen, Thomas Kjærgaard, Johannes Martin Schmid
Respiratory Medicine and Research|April 23, 2023
Screening for impaired pulmonary function using peak expiratory flow: Performance of different interpretation strategiesMartin Rune Hassan Hansen, Johannes Martin Schmid
Respiratory Medicine|December 2, 2020
Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatmentAnne Sofie Bjerrum, Tina Skjold, Johannes Martin Schmid
BMJ Case Reports|November 3, 2019
New-onset asthma in a bilateral lung transplant patientDaniel Benjamin Fyenbo, Kristine Bruun Degn, Johannes Martin Schmid, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2014
Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapyJohannes Martin Schmid, Peter Adler Würtzen, Ronald Dahl, et al.
BMJ Open|September 15, 2025
Acceptability and feasibility of a need-supportive intervention to increase trial retention: a randomised feasibility study within a randomised controlled allergy trial in DenmarkAnne Poder Petersen, Johannes Martin Schmid, Hans Jürgen Hoffmann, et al.
The Journal of Allergy and Clinical Immunology|July 5, 2015
Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extractJohannes Martin Schmid, Peter Adler Würtzen, Ronald Dahl, et al.
The Journal of Allergy and Clinical Immunology|July 18, 2020
Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A 3-year randomized placebo-controlled trialSøren Helbo Skaarup, Johannes Martin Schmid, Tina Skjold, et al.
Clinical and Translational Allergy|May 28, 2016
Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot studyJohannes Martin Schmid, Homaira Nezam, Hans Henrik Torp Madsen, et al.
Allergy|November 10, 2025
Low-Dose Intralymphatic Immunotherapy for Grass Pollen Allergy is Both Safe and EffectiveBjarke Hviid-Vyff, Søren Helbo Skaarup, Amber Duin, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
European Clinical Respiratory Journal|January 28, 2025
Idiopathic subglottic stenosis in a 32-year-old pregnant womanBo Toennesen, Thomas Kjærgaard, Johannes Martin Schmid
Respiratory Medicine and Research|April 23, 2023
Screening for impaired pulmonary function using peak expiratory flow: Performance of different interpretation strategiesMartin Rune Hassan Hansen, Johannes Martin Schmid
Respiratory Medicine|December 2, 2020
Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatmentAnne Sofie Bjerrum, Tina Skjold, Johannes Martin Schmid
BMJ Case Reports|November 3, 2019
New-onset asthma in a bilateral lung transplant patientDaniel Benjamin Fyenbo, Kristine Bruun Degn, Johannes Martin Schmid, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2014
Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapyJohannes Martin Schmid, Peter Adler Würtzen, Ronald Dahl, et al.
BMJ Open|September 15, 2025
Acceptability and feasibility of a need-supportive intervention to increase trial retention: a randomised feasibility study within a randomised controlled allergy trial in DenmarkAnne Poder Petersen, Johannes Martin Schmid, Hans Jürgen Hoffmann, et al.
The Journal of Allergy and Clinical Immunology|July 5, 2015
Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extractJohannes Martin Schmid, Peter Adler Würtzen, Ronald Dahl, et al.
The Journal of Allergy and Clinical Immunology|July 18, 2020
Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A 3-year randomized placebo-controlled trialSøren Helbo Skaarup, Johannes Martin Schmid, Tina Skjold, et al.
Clinical and Translational Allergy|May 28, 2016
Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot studyJohannes Martin Schmid, Homaira Nezam, Hans Henrik Torp Madsen, et al.
Allergy|November 10, 2025
Low-Dose Intralymphatic Immunotherapy for Grass Pollen Allergy is Both Safe and EffectiveBjarke Hviid-Vyff, Søren Helbo Skaarup, Amber Duin, et al.
Pageof 4